Ibali leGentolex lingalandwa emva kwehlobo lika-2013, iqela labantu abatsha abanombono kwishishini lokudala amathuba okudibanisa ihlabathi kunye neenkonzo ezingcono kunye nesiqinisekiso semveliso.
Ummandla wokwakha umzi-mveliso oziimitha ezingama-250,000 phantsi komgangatho wamazwe ngamazwe ukunika izisombululo eziguquguqukayo, ezikhawulezayo nezineendleko ezifanelekileyo.
I-Gentolex inikezela ngoluhlu olubanzi lwee-APIs kunye nabaphakathi kwisifundo sophuhliso kunye nesicelo sorhwebo kunye nomgangatho we-cGMP ukusuka kwintsebenziswano yexesha elide.Amaxwebhu kunye neZatifikethi zixhaswa kubathengi kwihlabathi liphela.
Sinamava atyebileyo okubonelela ngeenkonzo ze-CRO kunye ne-CDMO kuyo yonke inkqubo yophuhliso lwamachiza e-peptide kwiiprojekthi ze-IND, NDA & ANDA, zibonelela ngesikhokelo esikhuselekileyo nesisebenzayo ukusuka kuphuhliso ukuya kwimveliso yorhwebo.
Kwabo bathengi bakhetha ukunqanda ukuntsonkotha kokujongana namanqaku amaninzi oqhagamshelwano, sibonelela ngeenkonzo zokuthengwa kwempahla ezongezelelweyo ezilungiselelweyo kunye neyona mithombo yobonelelo iphezulu kunye nebanzi.
Ibali leGentolex lingalandwa emva kwehlobo lika-2013, iqela labantu abatsha abanombono kwishishini lokudala amathuba okudibanisa ihlabathi kunye neenkonzo ezingcono kunye nesiqinisekiso semveliso.Ukuza kuthi ga ngoku, kunye neminyaka yokuqokelela, i-Gentolex Group iye yakhonza abathengi abavela kumazwe angaphezu kwe-15 kumazwekazi angama-5, ngokukodwa, amaqela abameli asekwa eMexico naseMzantsi Afrika, kungekudala, amaqela abameli abaninzi baya kusekwa kwiinkonzo zoshishino.
Ngo-2021-12-06, ixesha lase-US, i-Acadia Pharmaceuticals (Nasdaq: ACAD) yabhengeza iziphumo ezilungileyo zodidi oluphezulu lweSigaba sesi-III solingo lwezonyango lomgqatswa wayo wechiza, iTrofinetide.Ulingo lwesigaba III, olubizwa ngokuba yiLavender, lusetyenziswa ikakhulu ukuhlola ukhuseleko nokusebenza kweTrofinetide kunyango lweRet...
Kwangoko ngo-2021-08-24, iCara Therapeutics kunye neqabane layo leshishini uVifor Pharma babhengeze ukuba i-kappa opioid receptor agonist yokuqala ye-felikefalin (KORSUVA™) yamkelwe yi-FDA kunyango lwezintso ezingapheliyo (CKD) izigulana. (ukurhawuzelela okuphakathi/okumandundu ngehemod...
Canada ixesha 2022-01-24, RhoVac, inkampani amayeza egxile kwi tumor immunology, wabhengeza ukuba isicelo salo patent (No. 2710061) isitofu sokugonya umhlaza peptide RV001 iya kugunyaziswa yi-Canadian Intellectual Property Office (CIPO).Ngaphambili, inkampani ibifumene amalungelo awodwa abenzi...